Eli Lilly FALLS SHORT of Endpoint and 4 Stocks Hitting 52-Week Highs
Kraft Foods Inc. (NYSE:KFT): MTV (NYSE:VIAB) will introduce a new type of multi-platform ad service today, which is the newest effort by a TV network to capture the attention of consumers who are watching TV while also surfing the Web or tweeting, according to the Wall Street Journal. PepsiCo (NYSE:PEP), Verizon (NYSE:VZ)and Kraft (NYSE:KFT) are to do test ads on that platform. The shares closed at $42.31, up $0.65 or 1.55% on the day. They have traded in a 52-week range of $31.88 to $42.00.
Eli Lilly And Company (NYSE:LLY) announced that the Phase III POINTBREAK trial did not meet its primary endpoint of improved overall survival for patients suffering with nonsquamous non-small cell lung cancer who were randomized to receive a combination of ALIMTA with bevacizumab and carboplatin induction followed by ALIMTA plus bevacizumab maintenance-the ALIMTA arm-compared to the combination of paclitaxel with bevacizumab and carboplatin followed by bevacizumab maintenance-the paclitaxel arm. The study did meet one secondary endpoint of improved progression-free survival for the ALIMTA arm. The shares closed at $46.81, up $1 or 2.18% on the day. They have traded in a 52-week range of $35.44 to $46.36.
Mccormick & Company (NYSE:MKC): By 2015, 20 percent of sales should be in emerging markets, up from 10 percent in 2011. The shares closed at $63.41, up $1.01 or 1.62% on the day. They have traded in a 52-week range of $43.62 to $62.69.
Nordion Inc. (NYSE:NDZ) gave an update on its YES-P clinical trial for TheraSphere, which is the company’s Yttrium-90 glass microsphere liver cancer treatment, by naming the principal investigators and contract research organization for the study. The YES-P trial targets enrollment of 350 patients at about 24 European sites, with more sites to be identified worldwide. The study is to follow a randomized two-armed design in one arm, patients are to undergo Y-90 radioembolization treatment with TheraSphere, while patients in the other arm are to receive sorafenib, which is the standard of care for advanced unresectable HCC. The shares closed at $10.69, up $0.19 or 1.81% on the day. They have traded in a 52-week range of $8.00 to $10.59.
News Corp. (NASDAQ:NWSA): Along with speculation that Amazon.com (NASDAQ:AMZN) intends to show off a video device for the living room along with tablets and e-readers at its event today, AllThingsD’s Peter Kafka claimed that Amazon made an offer to purchase Web TV box maker Roku earlier in the year, citing sources. The shares closed at $24.50, up $0.75 or 3.14% on the day. They have traded in a 52-week range of $14.72 to $24.05.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>